Airsculpt Technologies vs SBC Medical
AIRS and SBC side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AIRS and SBC compare
SBC Medical is the larger company, worth 9.3 times as much as Airsculpt Technologies ($539M against $58.1M).
Airsculpt Technologies grew revenue faster over the last twelve months (−6.3% versus −6.9% for SBC Medical).
SBC Medical keeps more of each dollar of sales as profit, with a net margin of 28.0% compared with −6.4% at Airsculpt Technologies.
SBC Medical scores higher on the StockData Score (12 against 4 for Airsculpt Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AIRS | SBC |
|---|---|---|
| Size and price | ||
| Market cap | $58.1M | $539M |
| Share price | $0.805 | $5.24 |
| Change, 1 year | −87.3% | 53.2% |
| Change, 5 years | −94.6% | – |
| Beta (5Y) | 2.44 | 0.44 |
| Employees | 330 | 863 |
| StockData Score | ||
| Total score | 4 | 12 (better) |
| Valuation score | 2 | 4 (better) |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 3 (better) |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 11.1× |
| P/S | 0.4× (better) | 3.1× |
| P/B | 0.5× (better) | 2.0× |
| EV/EBITDA | 16.0× | 5.4× (better) |
| P/FCF | – | 8.7× |
| FCF yield | −4.4% | 11.5% (better) |
| Fair value | – | $8.64 |
| Margin of safety | – | 39.3% |
| Growth | ||
| Revenue growth (TTM) | −6.3% (better) | −6.9% |
| Revenue growth, 5Y average | 19.3% | – |
| Net income growth (TTM) | – | 47.1% |
| EPS growth (TTM) | – | 46.9% |
| Profitability | ||
| Gross margin | 60.2% | 71.9% (better) |
| Operating margin | −4.7% | 37.3% (better) |
| Net margin | −6.4% | 28.0% (better) |
| FCF margin | −1.7% | 35.3% (better) |
| Return on equity | −10.1% | 19.3% (better) |
| Return on invested capital | −4.2% | 50.7% (better) |
| Financial health | ||
| Debt / equity | 0.35 | 0.00 (better) |
| Net debt / EBITDA | 4.33 (better) | −2.69 |
| Interest coverage | −1.4× | 195× (better) |
| Current ratio | 0.85 | 3.31 (better) |
| Altman Z-score | 0.68 | 4.95 (better) |
| Piotroski F-score | 3 | 4 (better) |
| Dividends and buybacks | ||
| Buyback yield | −54.6% | – |
| Shareholder yield | −54.6% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 63.3% | 8.3% |
| Held by insiders | 76.5% | 82.0% |
| Insider net buying, 12 months | $2.0M (better) | −$20.1M |
| Short interest, % of float | 19.1% | – |
Go deeper
- AIRS stock overview
- AIRS income statement
- AIRS valuation and score
- SBC stock overview
- SBC income statement
- SBC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.